RNA Analysis Market (By Technology: Real Time-PCR (qPCR) Technology, Microarray Technology, Sequencing Technology; By Product: Instruments, Kits & Reagents, Services; By Application: Construction of RNA Expression Atlas, Epigenetics, Infectious Diseases and Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics; By End-use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global RNA Analysis market size is expected to be worth around US$ 30.48 billion by 2030, according to a new report by Vision Research Reports.

The global RNA Analysis market size was valued at US$ 10.28 billion in 2020 and is anticipated to grow at a CAGR of 14.44% during forecast period 2021 to 2030.

RNA Analysis Market Size 2022 to 2030

Report Coverage

Report Scope Details
Market Size US$ 30.48 billion by 2030
Growth Rate CAGR of 14.44% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Technology, Product, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Agilent Technologies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.;QIAGEN; Thermo Fisher Scientific, Inc; Eurofins Scientific; Merck KGaA; Pacific Bioscience of California, Inc; Affymetrix, Inc; Danaher Corporation; Promega

Growth Factors

Technological advancements in this market can be attributed to the increasing applications of transcriptome sequencing into life science for capturing polyadenylated RNA.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Collaborations between research institutes for the use of transcriptomics in various applications would drive market growth.

By Technology Analysis

Based on technology, real-time-PCR (qPCR) technology dominated the market with the largest revenue share of more than 56% in 2020 due to increased use of PCR for COVID-19 diagnostic across the globe. 

The technology is considered to be highly sensitive and quantitative and one of the most suitable methods for interrogating a comparatively small number of transcripts in a broad set of samples. PCR offers relatively high-sensitivity detection of SARS-CoV-2, evaluation of viral RNA in various types of clinical samples, detecting SARS-CoV-2 mutations, and evaluation of anti-SARS-CoV-2 drugs.

The sequencing segment is anticipated to witness substantial growth over the forecast years owing to advancements in the next-generation and SMRT sequencing technology. The presence of several companies providing single-cell RNA sequencing services and the advent of bioinformatics algorithms are also driving the growth of this market.

By Product Analysis

Based on products, the kits & reagents segment accounted for the largest revenue share of over 58% in2020. Rising requirements for high-quality reagents and kits coupled with repeated use of reagents and media in transcriptome studies drive the segment growth. 

Growing R&D activities in the pharmaceutical sector and increasing government investments in life science research are the major factors expected to fuel this market for consumables.NGS roots have begun with the adaptation of some SMART cDNA synthesis technology mainly for RNA-sequencing applications. 

By Application Analysis

The Infectious diseases and pathogenesis segment accounted for a substantial market share of more than 20% in 2020 and is closely followed by alternative RNA splicing applications. Identification of susceptible cells is crucial for understanding the pathogenic mechanism. 

The RNA structure and molecular dynamics segment is expected to expand at a significant CAGR from 2021 to 2028 as pharmaceutical importance for RNA in the development of a new drug is gradually growing.

By End-use Analysis

The government institutes & academic centers segment reported the highest revenue share of over 32% in 2020. The rising adoption of high throughput technologies for the effective process of RNA analysis by government institutes and academic centersis driving the segment growth.

Research in drug discovery is also contributing to the market that is followed by clinical diagnostics. For instance, in April 2021, researchers developed TORNADO-seq, an RNA sequencing-based drug discovery platform to monitor the expression of the large gene for a detailed study of cellular phenotypes in organoids.

The Italian Institute of Technology has signed a partnership agreement with European Molecular Biology Laboratory to expand their collaboration in research. This collaboration is anticipated to strengthen their database and share resources for the study. 

By Regional Analysis

North America accounted for the maximum revenue share of more than 46% in 2020. The growth is attributed to the rapid development of structure-based drug designs, increasing focus on transcriptomics research, and high investment in biopharmaceutical research and development. 

Growing investments by governments &enterprises are accelerating biotechnology research in Asia Pacific countries. The Japanese government and non-government organizations are highly supportive of the growth of biotechnology research in the country and provide funds to research in the fields of medicine and life sciences. 

Increasing focus on Asia Pacific countries is owing to the low-cost manufacturing services, is expected to provide growth opportunities for the manufacturers.

Key Players 

  • Agilent Technologies, Inc.

  • F. Hoffmann-La Roche AG

  • Illumina, Inc.

  • QIAGEN

  • Thermo Fisher Scientific, Inc.

  • Eurofins Scientific

  • Merck KGaA

  • Bio-Rad Laboratories, Inc.

  • Pacific Bioscience of California, Inc.

  • Affymetrix, Inc.

  • Danaher Corporation

  • Promega

Market Segmentation

  • By Technology 

    • Real Time-PCR (qPCR) Technology

    • Microarray Technology

    • Sequencing Technology

    • Others

  • By Product 

    • Instruments

    • Kits & Reagents

      • miRNA & siRNA

      • Reverse Transcriptases & RT-PCR

      • RNA Extraction & Purification

      • RNA Interference

      • Others

    • Services

  • By Application 

    • Construction of RNA Expression Atlas

    • Epigenetics

    • Infectious Diseases and Pathogenesis

    • Alternative RNA Splicing

    • RNA Structure & Molecular Dynamics

    • Development & Delivery of RNA Therapeutics

    • Others

  • By End-use 

    • Government Institutes & Academic Centers

    • Pharmaceutical & Biotechnology Companies

    • Contract Research Organizations (CROs)

    • Hospitals & Clinics

  • Regional

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • Italy

      • Spain

      • France

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

The RNA Analysis market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of RNA Analysis market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global RNA Analysis market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNA Analysis market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted RNA Analysis market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the RNA Analysis capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of RNA Analysis by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global RNA Analysis market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major RNA Analysis market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of RNA Analysis market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the RNA Analysis industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

RNA Analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to RNA Analysis market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of RNA Analysis market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new RNA Analysis market. These factors have benefited the growth of the global market for RNA Analysis. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for RNA Analysis. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of RNA Analysis are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global RNA Analysis Market, By Technology

7.1.  RNA Analysis Market, by Technology, 2021-2030

7.1.1.    Real Time-PCR (qPCR) Technology

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Microarray Technology

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Sequencing Technology

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global RNA Analysis Market, By Product

8.1.  RNA Analysis Market, by Product, 2021-2030

8.1.1.    Instruments

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Kits & Reagents

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Services

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global RNA Analysis Market, By Application

9.1.  RNA Analysis Market, by Application, 2021-2030

9.1.1.    Construction of RNA Expression Atlas

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Epigenetics

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Infectious Diseases and Pathogenesis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Alternative RNA Splicing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    RNA Structure & Molecular Dynamics

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Development & Delivery of RNA Therapeutics

9.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global RNA Analysis Market, By End-use

10.1.        RNA Analysis Market, by End-use, 2021-2030

10.1.1.  Government Institutes & Academic Centers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Pharmaceutical & Biotechnology Companies

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Contract Research Organizations (CROs)

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Hospitals & Clinics

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global RNA Analysis Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.2.  Market Revenue and Forecast, by Product (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.2.  Market Revenue and Forecast, by Product (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.2.  Market Revenue and Forecast, by Product (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.2.  Market Revenue and Forecast, by Product (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.2.  Market Revenue and Forecast, by Product (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Agilent Technologies, Inc.

12.1.1.  Company Overview

12.1.2.  Technology Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              F. Hoffmann-La Roche AG

12.2.1.  Company Overview

12.2.2.  Technology Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Illumina, Inc.

12.3.1.  Company Overview

12.3.2.  Technology Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              QIAGEN

12.4.1.  Company Overview

12.4.2.  Technology Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Thermo Fisher Scientific, Inc.

12.5.1.  Company Overview

12.5.2.  Technology Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Eurofins Scientific

12.6.1.  Company Overview

12.6.2.  Technology Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Merck KGaA

12.7.1.  Company Overview

12.7.2.  Technology Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Bio-Rad Laboratories, Inc.

12.8.1.  Company Overview

12.8.2.  Technology Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Pacific Bioscience of California, Inc.

12.9.1.  Company Overview

12.9.2.  Technology Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Affymetrix, Inc.

12.10.1.               Company Overview

12.10.2.               Technology Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers